We considered GP IIb/ IIIa inhibitors. Our cardiologists decided against as
they seemed just to buy time for angioplasty, which we could provide quickly
(at least by UK standards) in any case. I didn't agree at the time but GUSTO
4 seems to have shown them to be right. Now I've come round to the view that
in the current state of evidence there may be better ways to spend our
money.
Matt Dunn
Warwick
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|